2m 2m 2m 2m 2m 2m 2m
BONE BIO (BBLG)
NASDAQ
$0.57+$0.02 (+3.85%)
Price as of Sep 11, 2026 7:49 PM EDT- $1.5MMarket Cap
- -74.14%1-Year Change
- BiotechnologyIndustry
BONE BIO (BBLG)
$0.57+$0.02 (+3.85%)
BBLG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.55 | ||
Change | -$0.01 (-1.82%) | ||
Open | $0.56 | ||
High | $0.56 | ||
Low | $0.55 | ||
Previous Close | $0.56 | ||
Volume | 18,504 | ||
30-Day Average Volume | 790,282 | ||
1-Week Change | -3.10% | ||
1-Month Change | -39.39% | ||
1-Year Change | -74.14% | ||
3-Year Change | -98.29% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 2.8M | ||
Total Assets | $4.4M | ||
Market Cap | $1.5M | ||
Enterprise Value | -$2.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$739,690.00 | ||
Free Cash Flow | -$518,440.00 | ||
EBIT | -$739,690.00 | ||
EBITDA | -$739,690.00 | ||
Net Working Capital | $3.9M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/10/2025 | ||
Earnings & Revenue